Skip to main content

Table 2 Serum lipid profiles of study participants by HAART status

From: Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon

Parameters HAART experienced Group (n = 157) HAART naïve Group (n = 52) p-value
Total cholesterol, mean ± SD 208.7 (71.9) 147.4 (44.6) < 0.0001
≥ 200 mg/dL 80 (51.0 %) 5 (9.6 %) < 0.0001
LDL-cholesterol, mean ± SD 117.6 (68.2) 65.9 (42.0) < 0.0001
≥ 130 mg/dL 58 (36.9 %) 4 (7.7 %) 0.0001
HDL-cholesterol, mean ± SD 67.0 (62.6) 62.5 (26.3) 0.6153
< 40 mg/dL 22 (14.0 %) 7 (13.5 %) 0.9257
Triglycerides, mean ± SD 117.2 (59.3) 97.7 (57.5) 0.0396
≥ 150 mg/dL 32 (20.4 %) 9 (17.3 %) 0.6257
TC/HDL-cholesterol ratio, mean ± SD 3.7 (2.6) 2.8 (1.7) 0.0205
≥ 5 24 (15.3 %) 3 (5.8 %) 0.0769
  1. HAART- Highly Active Antiretroviral Therapy, TC-Total Cholesterol; HDL-High-Density Lipoprotein, LDL-Low- Density Lipoprotein, SD-Standard Deviation